AUS
NZ
UK
CA
USA
IND
Health
Catalyst Pharmaceuticals (NASDAQ:CPRX) Nasdaq Index Clinical Depth
December 17, 2025 12:00 AM PST| By Anmol KhazanchiHighlights,Catalyst Pharmaceuticals advances therapies for rare neurological conditions,Focused commercial portfolio supports specialised patient populations,Research-driven structure strengthens long-term development pathways,Catalyst Pharmaceutical...
Masimo Corporation (NASDAQ:MASI) Nasdaq Composite Health Analytics
December 17, 2025 12:00 AM PST| By Anmol KhazanchiMasimo Corporation (NASDAQ:MASI) advances noninvasive patient monitoring through accurate, connected clinical technologies, maintaining visibility within healthcare-focused activity across the nasdaq composite.
Kodiak Sciences Inc (NASDAQ:KOD) Advances Retinal Biologic Research
December 17, 2025 12:00 AM PST| By Anmol KhazanchiKodiak Sciences Inc operates as a clinical-stage biopharmaceutical company developing biologic therapies for retinal diseases, with research programs centered on chronic and progressive vision-related conditions.
DBV Technologies (NASDAQ:DBVT) Builds Long-Term Clinical Direction
December 17, 2025 12:00 AM PST| By Anmol KhazanchiDBV Technologies is a clinical-stage biopharmaceutical company developing epicutaneous immunotherapy platforms focused on food allergies, emphasizing noninvasive delivery, controlled dosing, and structured clinical evaluation.
ResMed Inc (NYSE:RMD) s&p 500 index Digital Health Footprint
December 17, 2025 12:00 AM PST| By Anmol KhazanchiResMed Inc develops sleep and respiratory care technologies through devices and digital platforms, appearing in broader healthcare conversations where the s&p 500 index is used as contextual market language.
Elevance Health (NYSE:ELV) S&P 500 Today Health Platform
December 17, 2025 12:00 AM PST| By Anmol KhazanchiElevance Health delivers integrated health benefits, pharmacy, and care services across the United States, remaining visible in broader healthcare discussions shaped by market conditions linked to s&p 500 today.
Elanco Animal Health (NYSE:ELAN) Shares Little Changed After Results
December 16, 2025 09:45 AM PST| By Anmol KhazanchiElanco Animal Health (NYSE:ELAN) offers comprehensive animal care solutions, spanning pet therapeutics, preventive care, livestock products, and global operational support across veterinary and agricultural sectors.
Fortrea Holdings Inc (NASDAQ:FTRE) Nasdaq Composite Drug Development
December 16, 2025 12:00 AM PST| By Anmol KhazanchiFortrea (NASDAQ:FTRE) delivers integrated clinical research services supporting biopharmaceutical development, appearing in broader healthcare discussions shaped by activity across the nasdaq composite.
Roivant Sciences Ltd (NASDAQ:ROIV) Nasdaq Futures Biopharma Platform
December 16, 2025 12:00 AM PST| By Anmol KhazanchiRoivant Sciences (NASDAQ:ROIV) supports biopharmaceutical innovation through its Vant-based platform, remaining visible in healthcare-focused market narratives shaped by movements within the nasdaq composite.
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Advances Protein Modulation Science
December 16, 2025 12:00 AM PST| By Anmol KhazanchiNurix Therapeutics focuses on targeted protein modulation using small-molecule science to advance clinical programs addressing cancer and immune-driven diseases through precision-based biotechnology research.
Nektar Therapeutics (NASDAQ:NKTR) Advances Immune Modulation Research
December 16, 2025 12:00 AM PST| By Anmol KhazanchiNektar Therapeutics focuses on immunotherapy research aimed at regulating immune system activity, advancing clinical programs across autoimmune and oncology areas through a science-driven development framework.
ImmuCell Corporation (NASDAQ:ICCC) Expands Biological Cattle Protection
December 16, 2025 12:00 AM PST| By Anmol KhazanchiImmuCell Corporation (NASDAQ:ICCC) develops biological products that support dairy and beef cattle health, focusing on disease prevention, immune support, and sustainable livestock productivity.
Zoetis Inc (NYSE:ZTS) S&P 500 Chart Underscores Healthcare Niche
December 16, 2025 12:00 AM PST| By Anmol KhazanchiZoetis operates globally across livestock and companion animal health markets, delivering veterinary medicines and vaccines while appearing in broader market discussions that include the s&p 500 chart.
Pfizer Inc (NYSE:PFE) Institutional Healthcare Role In S&P 500 Today
December 16, 2025 12:00 AM PST| By Anmol KhazanchiPfizer (NYSE:PFE) supports global healthcare systems through diversified therapeutics, research-driven development, and large-scale manufacturing, remaining prominent in healthcare discussions shaped by S&P 500 today.
Kyverna (NASDAQ:KYTX) Reports Positive Phase 2 Data for CAR T Therapy in Stiff Person Syndrome
December 15, 2025 05:32 PM PST| By Team Kalkine MediaHighlights,Miv-cel met the primary and all secondary efficacy endpoints at Week 16 with statistically significant improvements in mobility and disease-related measures.,Eighty-one percent of patients achieved more than a 20% improvement in the timed...
Agilent Technologies (NYSE:A) Shares Rise After Revenue Growth
December 15, 2025 08:39 AM PST| By Anmol KhazanchiAgilent Technologies (NYSE:A) expands capabilities in life sciences and diagnostics, offering laboratory instruments, automation platforms, and services to enhance research and operational efficiency.
Mettler-Toledo (NYSE:MTD) Shares Little Changed in Trading Session
December 15, 2025 08:34 AM PST| By Anmol KhazanchiMettler-Toledo International (NYSE:MTD) operates globally, offering laboratory instruments, analytical solutions, and LabX software, serving research and industrial sectors with advanced scientific precision.
Avantor (NYSE:AVTR) Shares Little Changed as Institutional Activity Seen
December 15, 2025 08:25 AM PST| By Anmol KhazanchiAvantor (NYSE:AVTR) operates globally, providing laboratory consumables, process materials, and integrated services to biopharma, healthcare, and industrial technology sectors.
Charles River Labs (NYSE:CRL) Shares Little Changed on Ownership Focus
December 15, 2025 08:15 AM PST| By Anmol KhazanchiCharles River Laboratories International (NYSE:CRL) operates globally in drug discovery, safety assessment, and manufacturing services, strengthening the biopharmaceutical research sector with integrated solutions.
Dyne Therapeutics, Inc. (NASDAQ:DYN) Nasdaq Index Genetic Therapy Pathways
December 15, 2025 12:00 AM PST| By Anmol KhazanchiDyne Therapeutics develops disease-modifying treatments for genetically driven muscle disorders, contributing to biotechnology discussions where the nasdaq index highlights research-focused clinical-stage companies.
